Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2
Helena W. Rodbard, Andrea Giaccari, Rosemarie Lajara, John Stewart, Paul S. Strumph, Juliana Oliveira, Pablo Lapuerta, Rita Castro
Entra nei temi di ricerca di 'Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2'. Insieme formano una fingerprint unica.